Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutogliptin in T2DM on Glimepiride +/- Metformin
NCT00947557Phase 3Terminated
- Sponsor
- Forest Laboratories
- Start
- Jul 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Dutogliptin with Placebo (2 arms). Primary endpoint: Hemoglobin A1c at 26 weeks. Started Jul 2009; status: terminated.
02
Drugs
dutogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00947557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00947557.